Searched for
CARDIOMETABOLIC DISEASES INDIA
Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
Eli Lilly sticks to premium pricing for its innovator drug ahead of generics waveEli Lilly remains optimistic about strong demand for its weight-loss and anti-diabetes injectable, tirzepatide (sold as Mounjaro), despite ...
French pharma giant Servier to invest €15 million to launch global single-pill platform 'GATINN' in IndiaFrench pharma group Servier is expanding in India with a €15 million investment to launch GATINN, a global platform for single pill combina...
Cipla plans deeper push in domestic market and chronic therapies over next 2–3 yearsCipla's incoming MD and CEO-designate, Achin Gupta, outlined a two-to-three-year strategy focusing on deepening the domestic market presenc...
10,000 steps a day may not be enough. A hidden factor could raise your heart attack risk, warn doctorsA new study highlights sleep's vital role in heart health, emphasizing that quality and consistency are as crucial as duration. Improving s...
Diabesity: It’s more than you thinkThe intertwined rise of obesity and type 2 diabetes, termed 'diabesity,' presents a significant health challenge in India. This condition, ...
Type 2 diabetes triggering heart attacks in the 30s: Why India’s youth are at risk?Type 2 diabetes is increasingly affecting young Indians, accelerating heart disease risks due to factors like genetics, visceral fat, and u...
From Clinic to Crisis: How Poor Follow-Up Fuels the Type 2 Diabetes EpidemicMany individuals with diabetes in India are unaware of their condition, leading to missed opportunities for early treatment and increased h...
Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other detailsNovo Nordisk has introduced its weight-loss drug, Wegovy, in India. This launch follows Eli Lilly's entry into the market. The company aims...
ICMR sets up India's first diabetes biobank in ChennaiIndia's first diabetes biobank has been established in Chennai by ICMR and MDRF. The biobank houses samples from two major studies, includi...
Diabetes management made easier: Your guide to a healthier lifestyleProactively collaborating with healthcare professionals for personalized strategies enhances diabetes management, leading to improved overa...
Do you take your meals on time? Late dinners can increase risk of heart attack, finds studyCVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart d...
Indian study finds air pollution can lead to increased type 2 diabetes riskA groundbreaking study published in the BMJ Open Diabetes Research and Care journal reveals a direct link between exposure to polluted air ...
India's most purchased drugs in the last decade are for cardiac ailments, diabetesAt around Rs 21,000 crore annually, cardiac medication forms the biggest therapy of drugs being bought by Indians today. A decade ago, it w...
Pandemic leads to a hidden epidemic: Over half of young urban Indians may develop diabetesThe risk of developing diabetes in 20-year-old men & women is 56% and 65%, respectively.
Spending too much time in the kitchen? Pollution-causing fumes may up heart attack riskExposure to indoor air pollution may even up stroke risk.
Don’t miss the diabetes warning bell! The numbers, symptoms to watch out forPrediabetes is a wake-up call, which, taken seriously, can prevent or put off diabetes.
Alere eyes over 3-fold jump in India revenue to Rs 1,000 croreCompany also plans to accelerate its export strategy in the Asia pacific region with the launch of this unit for manufacturing care diagnos...
- Symposium on new drug discovery begins at Zydus Research Centre
The symposium is to address various aspects related to new drug discovery with a focus on cancer, inflammation, cardiometabolic diseases an...